Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients

被引:82
|
作者
Esposti, Luca Degli [1 ]
Saragoni, Stefania [1 ]
Benemei, Silvia [3 ]
Batacchi, Paolo [2 ]
Geppetti, Pierangelo [3 ]
Di Bari, Mauro [3 ]
Marchionni, Niccolo [3 ]
Sturani, Alessandra [4 ]
Buda, Stefano [1 ]
Esposti, Ezio Degli [4 ]
机构
[1] CliCon Srl Hlth Econ & Outcomes Res, Ravenna, Italy
[2] Pharmaceut Policy Dept, Local Hlth Unit Florence, Florence, Italy
[3] Univ Florence, CIRFF, Florence, Italy
[4] Policlin Umberto 1, Outcome Res Unit, Rome, Italy
来源
CLINICOECONOMICS AND OUTCOMES RESEARCH | 2011年 / 3卷
关键词
antihypertensive drug therapy; adherence; all-cause mortality; stroke; acute myocardial infarction;
D O I
10.2147/CEOR.S15619
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: To evaluate adherence to antihypertensive therapy (AHT) and the association between adherence to AHT, all-cause mortality, and cardiovascular (CV) morbidity in a large cohort of patients newly treated with antihypertensives in a clinical practice setting. Methods: An administrative database kept by the Local Health Unit of Florence (Italy) listing patient baseline characteristics, drug prescription, and hospital admission information was used to perform a population-based retrospective study including patients newly treated with antihypertensives, >= 18 years of age, with a first prescription between January 1, 2004 and December 31, 2006. Patients using antihypertensives for secondary prevention of CV disease, occasional spot users, and patients with early CV events, were excluded from the study cohort. Adherence to AHT was calculated and classified as poor, moderate, good, and excellent. A Cox regression model was conducted to determine the association among adherence to AHT and risk of all-cause mortality, stroke, or acute myocardial infarction. Results: A total of 31,306 patients, 15,031 men (48.0%), and 16,275 women (52.0%), with a mean age of 60.2 +/- 14.5 years was included in the study. Adherence to AHT was poor in 8038 patients (25.7% of included patients), moderate in 4640 (14.8%), good in 5651 (18.1%), and excellent in 12,977 (41.5%). Compared with patients with poor adherence (hazard ratio [HR] = 1), the risk of all-cause death, stroke, or acute myocardial infarction was significantly lower in patients with good (HR = 0.69, P < 0.001) and excellent adherence (HR = 0.53, P < 0.001). Conclusions: These findings indicate that suboptimal adherence to AHT occurs in a substantial proportion of patients and is associated with poor health outcomes already in primary prevention of CV diseases. For health authorities, this preliminary evidence underlines the need for monitoring and improving medication adherence in clinical practice.
引用
收藏
页码:47 / 54
页数:8
相关论文
共 50 条
  • [31] Antihypertensive medication adherence and associated factors among adult hypertensive patients at Jimma University Specialized Hospital, southwest Ethiopia
    Asgedom S.W.
    Atey T.M.
    Desse T.A.
    BMC Research Notes, 11 (1)
  • [32] The association of angiotensin receptor blocker-based combination therapy with persistence and adherence in newly treated, uncomplicated hypertensive patients
    Ah, Young-Mi
    Shin, Jaekyu
    Lee, Ju-Yeun
    PATIENT PREFERENCE AND ADHERENCE, 2019, 13 : 241 - 248
  • [33] Determinants of medication adherence among hypertensive patients using the Pender's health promotion model
    Goudarzi, Hossein
    Barati, Majid
    Bashirian, Saeed
    Moeini, Babak
    JOURNAL OF EDUCATION AND HEALTH PROMOTION, 2020, 9 (01)
  • [34] Adherence to Antihypertensive Medication in the older hypertensive patients: the role of blood pressure measurement assistance
    Nalotova, Elena N.
    Alesinskiy, Michail M.
    Berezin, Alexander E.
    Nalotov, Sergey V.
    PHARMACEUTICAL BIOPROCESSING, 2016, 4 (05) : 90 - 94
  • [35] Routine urinary detection of antihypertensive drugs for systematic evaluation of adherence to treatment in hypertensive patients
    Hamdidouche, Idir
    Jullien, Vincent
    Boutouyrie, Pierre
    Billaud, Eliane
    Azizi, Michel
    Laurent, Stephane
    JOURNAL OF HYPERTENSION, 2017, 35 (09) : 1891 - 1898
  • [36] An evaluation of the impact of patient cost sharing for antihypertensive medications on adherence, medication and health care utilization, and expenditures
    Pesa, Jacqueline A.
    Van Den Bos, Jill
    Gray, Travis
    Hartsig, Colleen
    McQueen, Robert Brett
    Saseen, Joseph J.
    Nair, Kavita V.
    PATIENT PREFERENCE AND ADHERENCE, 2012, 6 : 63 - 72
  • [37] Adherence with cardiovascular medications and the outcomes in patients with coronary arterial disease: "Real-world" evidence
    Chen, Chen
    Li, Xiaoqing
    Su, Yuhao
    You, Zhigang
    Wan, Rong
    Hong, Kui
    CLINICAL CARDIOLOGY, 2022, 45 (12) : 1220 - 1228
  • [38] Determinants of adherence to anti-hypertensive medications among adult hypertensive patients on follow-up in Hawassa Referral Hospital: A case-control study
    Getenet, Atsede
    Tesfa, Mulugeta
    Ferede, Aster
    Molia, Yalew
    JRSM CARDIOVASCULAR DISEASE, 2019, 8
  • [39] Barriers to and determinants of medication adherence among hypertensive patients attended National Health Service Hospital, Sunderland
    Khan, Muhammad Umair
    Shah, Shahjahan
    Hameed, Tahir
    JOURNAL OF PHARMACY AND BIOALLIED SCIENCES, 2014, 6 (02): : 104 - 108
  • [40] Adherence to Hypertensive Treatment among Vietnamese Patients in New Orleans
    Vo, David
    Do, Mai
    Nguyen, Diem
    Winfrey, Keith
    SOUTHERN MEDICAL JOURNAL, 2023, 116 (01) : 10 - 14